title: Global Delivery of Human Papillomavirus Vaccines.
abstract: Worldwide, cervical cancer is the fourth most common cancer among women. Human papillomavirus (HPV) vaccination, if broadly implemented, has the potential to significantly reduce global rates of morbidity and mortality associated with cervical and other HPV-related cancers. More than 100 countries around the world have licensed HPV vaccines. As of February, 2015, there were an estimated 80 national HPV immunization programs and 37 pilot programs. This article discusses global implementation of HPV vaccination programs and issues such as vaccine financing and different approaches to HPV vaccine delivery.
authors.affiliation: Division of Social and Behavioural Health Sciences, Dalla Lana School of Public Health, University of Toronto, 155 College Street, 6th Floor, Toronto, Ontario, M5T 3M7, Canada.
authors.forename: Jannah
authors.initials: J
authors.lastname: Wigle
authors.affiliation: W.F. Connell School of Nursing, Boston College, 140 Commonwealth Avenue, Chestnut Hill, MA 02467, USA.
authors.forename: Holly B
authors.initials: HB
authors.lastname: Fontenot
authors.affiliation: Department of Pediatrics, Indiana University School of Medicine, 410 West 10th Street, HS 1001, Indianapolis, IN 46202, USA. Electronic address: gzimet@iu.edu.
authors.forename: Gregory D
authors.initials: GD
authors.lastname: Zimet
mesh_terms: D000293:Adolescent; D003153:Community Health Services; D005260:Female; D014943:Global Health; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D008297:Male; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D012572:School Health Services; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology
chemical_list: D053918:Papillomavirus Vaccines
keywords: Global; HPV; Human papillomavirus; Immunization; Progress; Vaccine